You can buy or sell Prothena and other stocks, options, ETFs, and crypto commission-free!
Prothena Corporation plc Ordinary Shares, also called Prothena, is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. Read More The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Dun Laoghaire, Dublin
52 Week High
52 Week Low
Guru FocusMar 15
Prothena Corp PLC (PRTA) Files 10-K for the Fiscal Year Ended on December 31, 2018
Prothena Corp PLC (NASDAQ:PRTA) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Prothena Corp PLC is a biotechnology company.
Expected May 7, After Hours